Literature DB >> 8341325

Characterization of mevalonate-labeled lipids isolated from parasite proteins in Schistosoma mansoni.

G Z Chen1, J L Bennett.   

Abstract

Adult paired schistosomes incubated for 3 days in radiolabeled mevalonate can effectively label at least 2 major proteins with apparent sizes of 25 and 43 kDa. The 25-kDa mevalonate-labeled proteins comigrated with proteins that could be labeled with GTP. The lipids attached to these proteins were removed and resolved by HPLC and found to comigrate with known samples of farnesol and geranylgeraniol. Homogenates of the schistosome when incubated with labeled farnesol pyrophosphate effectively labeled a protein(s) with an apparent molecular weight of 43 kDa while homogenates incubated in the presence of labeled geranylgeranyl pyrophosphate-labeled schistosome proteins with an apparent molecular weight of 25 kDa. Our results demonstrate that Schistosoma mansoni has the ability to covalently attach farnesol and geranylgeranyl to low-molecular weight proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8341325     DOI: 10.1016/0166-6851(93)90226-n

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  5 in total

1.  Limonene arrests parasite development and inhibits isoprenylation of proteins in Plasmodium falciparum.

Authors:  I C Moura; G Wunderlich; M L Uhrig; A S Couto; V J Peres; A M Katzin; E A Kimura
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

2.  Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units.

Authors:  A S Couto; E A Kimura; V J Peres; M L Uhrig; A M Katzin
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

3.  Characterization of potential drug targets farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase in Schistosoma mansoni.

Authors:  Peter D Ziniel; Janish Desai; Cynthia L Cass; Craig Gatto; Eric Oldfield; David L Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

4.  Oral vaccination based on DNA-chitosan nanoparticles against Schistosoma mansoni infection.

Authors:  Carolina R Oliveira; Cíntia M F Rezende; Marina R Silva; Olga M Borges; Ana P Pêgo; Alfredo M Goes
Journal:  ScientificWorldJournal       Date:  2012-04-22

5.  Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis.

Authors:  Liliana Rojo-Arreola; Thavy Long; Dan Asarnow; Brian M Suzuki; Rahul Singh; Conor R Caffrey
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.